Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1‐year Overall Survival of Patients With Newly Diagnosed MGMT‐promoter Unmethylated Glioblastoma. This evidence concerns the gene MGMT and glioblastoma.